(Q34341299)

1 August 2017

1 reference

title

Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease (English)

1 reference

1 August 2017

1 reference

David J Burn

1

0 references

author name string

Alexander I Tröster

series ordinal

2

1 reference

1 August 2017

publication date

1 September 2004

1 reference

Journal of Geriatric Psychiatry and Neurology

1 August 2017

published in

1 reference

1 August 2017

volume

17

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

172-180

1 reference

Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Mental symptoms in Parkinsonian patients treated with L-dopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Visual hallucinations in Parkinson's disease: a review and phenomenological survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Early dopaminergic drug-induced hallucinations in parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Anticholinergic therapy and dementia in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Dopaminergic modulation of visual-spatial working memory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Dopaminergic modulation of cortical function in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Selegiline and manic behavior in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

The straight dope on addiction to dopamimetic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Behavioral complications of early pallidotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Visual hallucinations induced by deep brain stimulation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Psychological Changes Following Surgical Treatment of Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Cognitive function in patients with Parkinson's disease undergoing stereotaxic thalamotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Staged bilateral pallidotomy for treatment of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Pallidotomy and quality of life in patients with Parkinson's disease: an early study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Neurocognitive and psychosocial correlates of ventroposterolateral pallidotomy surgery in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Unilateral pallidotomy in PD: a controlled study of cognitive and behavioral effects. The Netherlands Pallidotomy Study (NEPAS) group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Cognitive functioning after pallidotomy for refractory Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Unilateral pallidotomy for Parkinson's disease: speech, motor, and neuropsychological outcome measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Unilateral subthalamotomy in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Behavioural disorders, Parkinson's disease and subthalamic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Mood changes with deep brain stimulation of STN and GPi: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Range of neuropsychiatric disturbances in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Deep brain stimulation of subthalamic nucleus: behavioural modifications and familiar relations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Transient manic behavior after pallidotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

The behavioral complications of pallidal stimulation: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Mania following deep brain stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Cognitive and behavioral changes after unilateral posteroventral pallidotomy: relationship with lesional data from MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Declines in switching underlie verbal fluency changes after unilateral pallidal surgery in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704267466

21 January 2018

Identifiers

DOI

10.1177/0891988704267466

1 reference

1 August 2017

1 reference